|
| |
SOLVO Biotechnology (Hungary) and
KRISHGEN BioSystems (India) announce Distribution and Service Representation
Agreement for SOLVO’s Membrane Transporter Assay Products and Services in India,
Singapore, Malaysia, Hong Kong, Thailand, Srilanka, Bangladesh, Pakistan and
Nepal.
Budapest, Hungary - Mumbai, India; 30th October,
2007 —SOLVO Biotechnology (SOLVO) and KRISHGEN BioSystems (KRISHGEN)
announced that they have formed a partnership to distribute and represent
SOLVO’s leading Membrane Transporter Assay Products and Services in India.
“Membrane transporters play a key role in the Absorption, Distribution,
Metabolism and Excretion of drugs at the most important pharmacological barriers
as well as in transporter mediated toxicity and drug-drug interactions, “
explained Gábor Heltovics, SOLVO’s Business Development Director. “SOLVO’s
leading assay systems are designed to detect interaction of compounds with a
wide array of membrane transporter proteins. We are very excited about the
opportunity to work with KRISHGEN BioSystems. This partnership will enhance the
availability of our products and services to many new customers in the Indian
subcontinent that shows tremendous growth potential.
About SOLVO Biotechnology:
SOLVO Biotechnology – “The Transporter Company” has been the pioneer and the
leader in the commercialization of Membrane Transporter technologies, including
therapeutics, diagnostics and drug discovery assays. The company offers drug
discovery products and services to pharmaceutical, biotechnology and consumer
goods industries, relevant to many therapeutic areas and product categories.
SOLVO Biotechnology provides a number of solutions for membrane transporter
assays to be used in drug discovery and development:
• Membrane Preparations – to be used for ATPase Assay and Vesicular Transport
Assay (indirect and direct uptake) measurements;
• Whole cell and Monolayer Assays;
• In vivo animal testing;
• Comprehensive Contract Screening Services;
• Sublicense for the Calcein Assay;
• Custom-Made Expression and Screening Systems.
SOLVO Biotechnology has an extensive development pipeline that is expected to
create a unique service platform that integrates, correlates and harmonizes DMPK
and ADME-Tox in vitro, ex vivo and in vivo research systems to evaluate the
membrane transporter profiles of drug candidates at various pharmacological
barriers and transporter mediated drug-drug interactions.
About KRISHGEN BioSystems:
KRISHGEN BIOSYSTEMS is a knowledge firm providing biotech solutions to the
research, diagnostic and biotech community in India. KRISHGEN has a focus on
distribution and marketing with a network all across South East Asia with a
major emphasis on India. SOLVO’s extensive product range will contribute in
offering a one-stop shop for DMPK/ADME-Tox Lab users.
CONTACT INFORMATION:
KRISHGEN BioSystems
SOLVO Biotechnology
Kalpesh Jain
Csilla Kegyes
+ 91-22-66372990
+36 23 503 940
http://www.krishgen.com
http://www.solvo.com
| |
|
